Integrative Mental Health Services Announces Use of Objective ADHD Testing Technology for Diagnosis and Treatment
Test Aims to Give Providers Increased Clinical Confidence Through Objective Data
Billings, Montana, January 20th, 2025—Integrative Mental Health Services (IMHS) today announces its adoption of QbTest, an objective ADHD test that provides clinicians with actionable data for unbiased decision-making and support. The test, created by the global leader in ADHD testing, Qbtech, is the first FDA-cleared solution to aid clinicians in diagnosing and treating ADHD in children, adolescents, and adults.
Qbtech offers both in-clinic and virtual testing capabilities. Administered on a computer, the assessment uses the built-in camera to measure core ADHD symptoms—activity, inattention, and impulsivity—through a 15-20-minute computer-based test. Results are instantly analyzed and presented in a report that compares a patient’s results with those of a group of people of the same age and sex at birth without ADHD.
Data from the QbTest can be utilized to enable clinicians to determine treatment effects more accurately and efficiently. This gives patients faster access to tailored treatment, which can increase their quality of life.
“Qbtech prides itself on providing our clinicians with industry-leading technology to treat their patients,” said Tony Doyle, Commercial Director at Qbtech. “ADHD has a significant role in the current mental health crisis, and incorporating objective data into the standard treatment of care is critical for patients to be treated effectively and efficiently.”
IMHS joins the growing list of nearly 10,000 clinicians globally, adopting objective measures to more accurately diagnose ADHD in their patients. Qbtech has administered more than 600,000 tests, with 120,000 of those conducted virtually. IMHS will be the first clinic in Montana to offer the Qbtest and with virtual capability, can serve the entire state.
The test will be offered at Integrative Mental Health Services starting January 20th, 2025. For more information visit (our website)
About Qbtech
Founded in 2002, Qbtech is a privately owned Swedish company that has developed leading solutions and products for improving the diagnosis, treatment, and follow-up of patients living with ADHD. Qbtech has operations in 13 countries and has offices in Stockholm, Houston, and London. Qbtech is an award-winning company recognized for their innovation, most recently winning the 2022 HSJ Partnership Award for the ‘Best Mental Health Partnership with the NHS’. www.qbtech.com
Media Contact:
Allison Sears, PMHNP ([email protected])